Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(14%)

Phase Distribution

Ph not_applicable
4
57%
Ph phase_1
2
29%
Ph early_phase_1
1
14%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
2(28.6%)
N/ANon-phased studies
4(57.1%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
83.3%
Most Advanced
Phase 1

Trials by Phase

Early Phase 11 (14.3%)
Phase 12 (28.6%)
N/A4 (57.1%)

Trials by Status

terminated114%
completed571%
unknown114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
COMBINATION PRODUCT
Total Trials
7